Stock Ratings / Health Care / NHC / earnings

SGRY (66) BKD (46) MD (74) ARDT (67) ⌘ Pro Terminal →

National HealthCare Corporation (NHC) Next Earnings Date & Expected ±8% Move

$212.16 +0.18% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

National HealthCare Corporation (NHC) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C+ • HOLD / WATCH Cap $3.32B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C+

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+4.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NHC)Realized 20D OHLCV Swing Band: ±8%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±8% Swing Band

±$16.97 Expected Swing

MODEL EARNINGS SETUP GAUGE

NHC Quantitative Pre-Earnings Setup: 69/100

Trailing EPS: $7.66 • YoY Revenue Growth: 16.1%

Model Bullish Setup (69/100)Model Risk Weight (31/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$1.52B	$120.0M	$148.6M	52%
FY 2024	2024-12-31	$1.31B	$101.9M	$79.7M	52%
FY 2023	2023-12-31	$1.14B	$66.8M	$111.2M	52%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating NHC & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on NHC
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NHC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +22.43%▼ SUPPORT BREAKDOWN

2026-10-30O $212.8H $213.3L $204.6C $212.2VOL 135.9K

RES: $249.7SUP: $225.6SMA50: $226.0SMA200: $194.1

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NHC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NHC Butterfly Map → + Track NHC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

21.2%/yr Implied 5Y Growth

vs. +16.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NHC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NHC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NHC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NHC)

Health Care Rank #99 of 1016 ⚔️ SGRY vs NHC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (NHC vs. SGRY, BKD, MD, ARDT)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, National HealthCare Corporation (NHC) ranks #99 by composite RQD confidence (69/100, grade C+) and #199 by equity capitalization ($3.32B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with NHC at 69/100 (C+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NHC ACTIVE National HealthCare Corporation	C+	69/100	27.7x	—	10.1%	+0.18%	$3.32B	Benchmark Subject
SGRY Surgery Partners Inc.	C+	66/100	—	—	9.9%	-0.13%	$3.04B	/sgry-vs-nhc →
BKD Brookdale Senior Living Inc.	D	46/100	—	26.2%	0.3%	+2.91%	$2.45B	/bkd-vs-nhc →
MD Pediatrix Medical Group Inc.	B	74/100	14.3x	—	33.6%	+0.93%	$2.37B	/md-vs-nhc →
ARDT Ardent Health Inc.	C+	67/100	12.8x	—	10.5%	+3.10%	$1.73B	/ardt-vs-nhc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001047335

In its most recent audited fiscal period (FY2025, filed 2025-12-31), National HealthCare Corporation (NHC) reported GAAP revenue of $1.52B (+16.1% vs. FY2024 revenue of $1.31B , and +33.0% cumulative change since FY2023) , GAAP net income of $120.0M, operating cash flow of $185.1M, and free cash flow of $148.6M (+86.5% YoY). On the balance sheet, NHC closed FY2025 with $1.53B in total assets against $32.5M in total debt (Altman Z-Score: 6.61, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.52B	$120.0M	$185.1M	$148.6M	$1.53B	$32.5M
FY2024 (FY)	2024-12-31	$1.31B	$101.9M	$107.3M	$79.7M	$1.52B	$129.5M
FY2023 (FY)	2023-12-31	$1.14B	$66.8M	$111.2M	$111.2M	—	—

3. NHC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NHC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, National HealthCare Corporation (NYSE: NHC) is rated C+ (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 69/100 at a spot price of $212.16 (+0.18% 1D, market cap $3.32B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, NHC ranks #99 in composite RQD confidence.

How does NHC compare to SGRY and BKD in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), NHC carries a Roarable C+ (69/100 RQD), trailing P/E of 27.7x, gross margin of —, and ROIC of 10.1%. By comparison, SGRY (Surgery Partners Inc.) holds a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B) and BKD (Brookdale Senior Living Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC 0.3%, cap $2.45B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NHC?

Per NHC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001047335), National HealthCare Corporation generated $1.52B in revenue (+16.1% YoY), $120.0M in net income, and $148.6M in free cash flow against $1.53B in total assets and $32.5M in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NHC trading relative to its 50-day, 200-day, and 52-week technical levels?

NHC last traded at $212.16 (+0.18% on volume of 145,696 shares), positioning the stock -6.11% below its 50-day simple moving average ($225.97) and +9.31% above its 200-day simple moving average ($194.09). Across its 52-week range of $118.14 to $248.20, NHC sits at the 72.3% percentile with a 14-day RSI of 35.1 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($195.19 to $229.13).